Results
|
881.
|
|
|
882.
|
|
|
883.
|
|
|
884.
|
|
|
885.
|
|
|
886.
|
|
|
887.
|
Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies. [electronic resource] by
- Zurth, Christian
- Koskinen, Mikko
- Fricke, Robert
- Prien, Olaf
- Korjamo, Timo
- Graudenz, Kristina
- Denner, Karsten
- Bairlein, Michaela
- von Bühler, Clemens-Jeremias
- Wilkinson, Gary
- Gieschen, Hille
Producer: 20200330
In:
European journal of drug metabolism and pharmacokinetics vol. 44
Availability: No items available.
|
|
888.
|
|
|
889.
|
|
|
890.
|
|
|
891.
|
Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma. [electronic resource] by
- Gomo, Charline
- Coriat, Romain
- Faivre, Lionel
- Mir, Olivier
- Ropert, Stanislas
- Billemont, Bertrand
- Dauphin, Alain
- Tod, Michel
- Goldwasser, Francois
- Blanchet, Benoit
Producer: 20120123
In:
Investigational new drugs vol. 29
Availability: No items available.
|
|
892.
|
|
|
893.
|
|
|
894.
|
|
|
895.
|
|
|
896.
|
Aminopyrazine CB1 receptor inverse agonists. [electronic resource] by
- Wustrow, David J
- Maynard, George D
- Yuan, Jun
- Zhao, He
- Mao, Jianmin
- Guo, Qin
- Kershaw, Mark
- Hammer, Jack
- Brodbeck, Robbin M
- Near, Kristen E
- Zhou, Dan
- Beers, David S
- Chenard, Bertrand L
- Krause, James E
- Hutchison, Alan J
Producer: 20080709
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
897.
|
|
|
898.
|
|
|
899.
|
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel. [electronic resource] by
- Sarantopoulos, John
- Mita, Alain C
- Wade, James L
- Morris, John C
- Rixe, Olivier
- Mita, Monica M
- Dedieu, Jean-François
- Wack, Claudine
- Kassalow, Laurent
- Lockhart, A Craig
Producer: 20150119
In:
Cancer chemotherapy and pharmacology vol. 74
Availability: No items available.
|
|
900.
|
|